AntimicrobialResearch Phase

Defensin HNP-1

Topical, Intravenous

Overview

Human neutrophil peptide 1 (HNP-1) is a 30-amino acid alpha-defensin produced by neutrophils as part of the innate immune response. It contains three stabilizing disulfide bonds and forms amphipathic structures that disrupt microbial membranes through electrostatic and hydrophobic interactions.

Mechanism of Action

HNP-1 exhibits antimicrobial activity against bacteria, fungi, and enveloped viruses, and also modulates immune cell function and inflammatory responses. As an endogenous peptide, it has been studied for potential therapeutic augmentation in immunocompromised states and chronic infections..

Research Summary & Key Findings

Preclinical studies have characterized HNP-1 antimicrobial mechanisms and immunomodulatory properties in vitro and in animal models. Elevated or reduced HNP-1 levels have been associated with various infectious and inflammatory diseases in observational clinical studies. No therapeutic clinical trials using exogenous HNP-1 administration have been conducted, and development challenges include synthesis cost and delivery optimization.

Clinical Status

Research Phase

Defensin HNP-1 is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

TopicalIntravenous

Related Peptides in Antimicrobial

Find a Provider

Find a verified provider who offers Defensin HNP-1 therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Defensin HNP-1.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.